OmniaBio opens largest advanced therapy facility

18 October 2024

OmniaBio, a subsidiary of Canada's Centre for Commercialization of Regenerative Medicine, has announced the opening of its new cell and gene therapy (CGT) manufacturing site.

The 120,000 square-foot facility is now the largest CGT-dedicated contract development and manufacturing organization (CDMO) facility in the region.

OmniaBio’s expansion is part of a broader trend among CDMOs, with companies like Exela Pharma, SK pharmteco, Symbiosis Pharmaceutical Services, and Afton Scientific also increasing production capacity in recent periods.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK